KLF6 not only directly upregulated NLPR3 (107) but also promoted NLRP3 by inhibiting miR-223-3p promoter activity (108) to activate NLRP3/Caspase-1/GSDMD pathway and accentuate septic acute kidney injury (AKI). The gene discussed is GSDMD; the disease is acute kidney injury.